Acrivon Therapeutics ACRV Growth Metrics (2021-2026)

NASDAQ ACRV
$1.83 +0.03 (+1.67%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Acrivon Therapeutics Quarterly Growth Metrics

Periods 19 quarters
Latest Jun 2026

Acrivon Therapeutics reported revenue growth of -50.29% and asset growth of -37.51% for the quarter ended Jun 2026. These growth metrics cover 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 70.03%72.26%-23.71%-29.19%44.07%42.09%42.18%46.32%-31.23%-32.32%-34.02%-38.85%-37.51%
Assets Growth (3y) 22.64%18.32%-10.55%-14.11%-14.77%
Assets (QoQ) 106.61%-6.09%-5.96%-5.60%-8.49%-12.83%91.32%-6.90%-8.43%-10.30%-10.07%-8.38%-10.72%-16.87%-8.11%
Capital Expenditures Growth (1y)Capex Growth (1y) 83.21%-93.98%-89.57%358.57%3,160.00%22.32%-28.15%-92.88%259.85%-9.10%-73.52%-75.86%-82.35%
Capital Expenditures Growth (3y)Capex Growth (3y) 82.08%-48.10%-22.86%28.27%-4.44%-17.57%-8.07%
Capital Expenditures (QoQ)Capex (QoQ) 202.92%158.80%-60.34%-41.08%-90.04%348.00%-29.19%-83.19%621.90%-16.38%-92.99%750.00%82.35%-75.64%-93.61%521.43%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 787.66%-70.36%-69.72%-54.60%-6.92%22.01%-10.48%20.83%45.40%10.56%59.12%-8.94%-18.45%4.22%-13.00%-1.14%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 129.03%-26.33%-24.44%-20.65%3.34%12.02%7.41%2.85%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 2,656.03%-8.87%-7.61%-61.75%-7.98%-6.88%38.51%-21.58%20.62%-31.68%86.96%-5.63%-8.29%-1.67%7.00%-15.49%17.21%-17.92%21.59%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -69,291.97%2,347.47%1,900.56%103.36%121.60%-37.28%-555.29%956.13%-29.82%228.44%122.09%-63.08%49.35%-31.68%-23.16%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y) 375.04%264.18%171.94%28.69%30.58%12.07%-8.23%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -202.92%-158.80%-4,101.12%-110.70%109.81%107.33%-92.16%1,254.62%-71.51%-1,605.03%118.19%-9.99%33.32%1.23%-69.61%264.13%-39.01%13.86%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -157.90%-34.91%-56.46%-50.38%-32.20%-50.42%-52.58%-76.66%-40.38%-14.35%-19.47%29.09%12.23%-5.13%10.52%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) -68.53%-32.39%-41.81%-23.50%-17.66%-21.83%-17.71%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -132.09%30.81%-11.97%-43.44%-21.41%19.77%-7.62%-26.11%-38.14%18.61%-24.60%-0.21%-12.53%14.97%26.05%-24.05%-34.79%27.64%
EBITDA Margin Growth (1y) -0.04M0.01M0.00M0.02M0.01M-0.05M-0.04M-0.05M-0.09M-0.08M
EBITDA Margin Growth (3y) -0.12M-0.13M
EBITDA Margin (QoQ) -0.01M0.00M-0.03M0.00M0.04M-0.01M-0.01M0.00M-0.02M453.00-0.03M-0.04M-0.02M
EBIT Growth (1y) -258.48%-132.90%-99.57%-161.94%-68.53%-111.69%-22.75%-38.13%-55.79%-18.53%-22.61%-5.65%21.69%19.39%8.12%17.58%
EBIT Growth (3y) -111.14%-80.12%-44.28%-56.36%-27.16%-26.47%-11.41%-6.35%
EBIT Margin Growth (1y) -0.04M0.01M0.00M0.02M0.01M-0.05M-0.04M-0.06M-0.09M-0.09M
EBIT Margin Growth (3y) -0.12M-0.13M
EBIT Margin (QoQ) -0.01M0.00M-0.03M0.00M0.04M-0.01M-0.01M0.00M-0.02M195.00-0.03M-0.04M-0.02M
EBIT (QoQ) -59.87%-68.90%17.85%-61.60%-3.86%-44.73%-7.83%-3.98%-30.46%16.08%-21.33%-17.27%0.74%13.19%-4.56%13.08%-2.18%1.06%6.20%
EBT Growth (1y) -258.48%-132.90%-99.57%-161.94%-68.53%-111.69%-22.75%-38.13%-55.79%-18.53%-22.61%-5.65%21.69%19.39%8.12%17.58%
EBT Growth (3y) -111.14%-80.12%-44.28%-56.36%-27.16%-26.47%-11.41%-6.35%
EBT Margin Growth (1y) -0.04M0.01M0.00M0.02M0.01M-0.05M-0.04M-0.06M-0.09M-0.09M
EBT Margin Growth (3y) -0.12M-0.13M
EBT Margin (QoQ) -0.01M0.00M-0.03M0.00M0.04M-0.01M-0.01M0.00M-0.02M195.00-0.03M-0.04M-0.02M
EBT (QoQ) -59.87%-68.90%17.85%-61.60%-3.86%-44.73%-7.83%-3.98%-30.46%16.08%-21.33%-17.27%0.74%13.19%-4.56%13.08%-2.18%1.06%6.20%
EPS (Basic) Growth (1y) -275.03%12.72%85.74%80.74%87.33%59.87%-25.41%17.85%10.11%22.42%29.68%-4.98%19.71%27.17%4.18%21.39%
EPS (Basic) Growth (3y) 24.70%35.23%49.90%45.04%54.95%39.02%5.46%12.15%
EPS (Basic) (QoQ) -80.62%-63.79%19.39%-57.27%57.97%73.24%-8.83%-3.45%-33.19%16.36%28.71%-13.20%-14.95%24.19%-6.43%13.42%-4.26%0.26%12.69%
EPS (Diluted) Growth (1y) -275.03%12.72%85.74%80.74%87.33%59.87%-25.41%17.85%10.11%22.42%29.68%-4.98%19.71%27.17%4.18%21.39%
EPS (Diluted) Growth (3y) 24.70%35.23%49.90%45.04%54.95%39.02%5.46%12.15%
EPS (Diluted) (QoQ) -80.62%-63.79%19.39%-57.27%57.97%73.24%-8.83%-3.45%-33.19%16.36%28.71%-13.20%-14.95%24.19%-6.43%13.42%-4.26%0.26%12.69%
FCF Margin Growth (1y) -0.06M-3.00-0.01M0.00M0.03M-0.05M-0.02M-0.05M-0.11M-0.07M
FCF Margin Growth (3y) -0.14M-0.12M
FCF Margin (QoQ) 0.01M0.00M-0.02M-0.04M0.07M-0.02M-0.01M-0.02M-700.000.01M-0.04M-0.08M0.03M
Free Cash Flow Growth (1y)FCF Growth (1y) -155.18%-28.86%-33.72%-41.15%-40.73%-57.25%-52.21%-86.74%-34.55%-9.47%-21.82%28.01%15.02%-4.89%12.59%
Free Cash Flow Growth (3y)FCF Growth (3y) -69.06%-30.42%-35.35%-23.80%-17.18%-21.77%-17.46%
Free Cash Flow (QoQ)FCF (QoQ) -134.67%21.91%-0.71%-38.26%-18.50%18.96%-6.31%-37.84%-32.41%21.56%-30.43%0.68%-7.73%12.71%22.93%-17.25%-32.97%27.26%
Net Cash Flow Growth (1y)NCF Growth (1y) -102.67%77.02%248.25%84.14%340.49%-461.82%109.30%65.71%-158.37%94.18%-87.18%-130.43%269.54%-1,021.08%168.00%
Net Cash Flow Growth (3y)NCF Growth (3y) -26.77%57.80%33.85%49.96%63.61%-54.21%-10.41%
Net Cash Flow (QoQ)NCF (QoQ) -109.20%21.91%-650.67%95.05%20.73%603.74%-180.31%175.00%-285.18%287.66%-113.16%-27.66%81.53%513.25%-336.48%193.93%-222.13%198.79%
Net Income Growth (1y) -276.97%-105.60%-76.68%-139.07%-57.27%-115.61%-29.24%-35.10%-55.13%-18.59%-19.37%-11.75%18.75%16.85%3.24%14.48%
Net Income Growth (3y) -109.52%-73.88%-39.69%-53.39%-25.62%-28.59%-14.29%-8.89%
Net Income (QoQ) -77.99%-66.24%19.39%-58.04%2.92%-42.86%-9.08%-3.97%-33.08%14.37%-14.02%-19.38%-1.74%13.80%-6.74%13.20%-4.12%-0.30%5.66%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -276.97%-106.36%-76.68%-139.07%-57.27%-114.95%-29.24%-35.10%-55.13%-18.74%-19.37%-11.75%18.75%17.01%3.24%14.48%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -109.52%-73.99%-39.69%-53.39%-25.62%-28.43%-14.29%-8.89%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -77.99%-66.24%19.39%-58.04%2.57%-42.33%-9.08%-3.97%-33.17%14.42%-14.02%-19.38%-1.93%13.97%-6.74%13.20%-4.12%-0.30%5.66%
Net Margin Growth (1y) -0.04M0.01M0.00M0.02M0.02M-0.05M-0.04M-0.06M-0.09M-0.09M
Net Margin Growth (3y) -0.12M-0.13M
Net Margin (QoQ) -0.01M0.00M-0.03M-158.000.04M-0.01M-0.01M0.00M-0.02M346.00-0.03M-0.04M-0.02M
Operating Income Growth (1y)Op. Inc Growth (1y) -258.48%-132.90%-99.57%-161.94%-68.53%-111.69%-22.75%-38.13%-55.79%-18.53%-22.61%-5.65%21.69%19.39%8.12%17.58%
Operating Income Growth (3y)Op. Inc Growth (3y) -111.14%-80.12%-44.28%-56.36%-27.16%-26.47%-11.41%-6.35%
Operating Income (QoQ)Op. Inc (QoQ) -59.87%-68.90%17.85%-61.60%-3.86%-44.73%-7.83%-3.98%-30.46%16.08%-21.33%-17.27%0.74%13.19%-4.56%13.08%-2.18%1.06%6.20%
Operating Margin Growth (1y) -0.04M0.01M0.00M0.02M0.01M-0.05M-0.04M-0.06M-0.09M-0.09M
Operating Margin Growth (3y) -0.12M-0.13M
Operating Margin (QoQ) -0.01M0.00M-0.03M0.00M0.04M-0.01M-0.01M0.00M-0.02M195.00-0.03M-0.04M-0.02M
Profit After Tax Growth (1y)PAT Growth (1y) -258.48%-132.90%-99.57%-161.94%-68.53%-111.69%-22.75%-38.13%-55.79%-18.53%-22.61%-5.65%21.69%19.39%8.12%17.58%
Profit After Tax Growth (3y)PAT Growth (3y) -111.14%-80.12%-44.28%-56.36%-27.16%-26.47%-11.41%-6.35%
Profit After Tax (QoQ)PAT (QoQ) -59.87%-68.90%17.85%-61.60%-3.86%-44.73%-7.83%-3.98%-30.46%16.08%-21.33%-17.27%0.74%13.19%-4.56%13.08%-2.18%1.06%6.20%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 621.38%-6.88%66.30%71.08%75.54%133.15%28.51%37.21%46.29%11.11%9.35%-0.49%-16.25%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) 148.89%34.12%32.70%32.68%29.08%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -2.74%-4.78%-0.85%1.42%73.69%-2.04%1.73%34.70%-4.26%4.59%8.47%2.31%-5.78%-4.83%-8.70%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M0.00M0.00M-297.00300.00441.000.00M0.00M0.00M0.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y) 0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 137.00-721.00-625.000.00M-801.000.00M515.00-506.00-660.00-639.00-217.00-263.00-817.00-641.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.00M0.00M0.00M-276.00374.00458.000.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) 0.00M-0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 209.00-784.00-702.000.00M-740.000.00M540.00-629.00-655.00-739.00-362.00-413.00-742.00-872.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -167.000.00M0.00M-304.00401.00614.000.00M0.00M0.00M0.00M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y) 0.00M-0.01M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.00M-779.00-724.000.00M-967.000.00M578.00-643.00-754.00-695.00-327.00-428.00-941.00-686.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.04M0.01M0.00M0.02M0.01M-0.05M-0.04M-0.06M-0.09M-0.09M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -0.12M-0.13M
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.01M0.00M-0.03M0.00M0.04M-0.01M-0.01M0.00M-0.02M195.00-0.03M-0.04M-0.02M
Revenue Growth (1y) -19.98%52.20%52.60%39.66%38.04%-35.78%-44.18%-47.23%-50.45%-50.29%
Revenue Growth (3y) -18.20%-21.38%
Revenue (QoQ) -2.05%-0.11%-4.30%-14.54%86.31%0.15%-12.42%-15.53%-13.33%-12.95%-17.20%-20.69%-13.04%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 888.89%441.12%6,515.00%1,052.79%1,108.99%85.90%26.38%32.76%13.72%21.22%13.37%10.12%6.54%-16.62%-42.47%-43.62%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y) 414.21%130.17%355.93%156.39%144.68%23.40%-6.24%-6.24%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 1,025.93%-86.84%482.50%14.59%516.10%60.85%1.51%20.18%-5.27%9.35%6.64%2.94%0.98%2.27%3.59%-0.41%-20.97%-29.44%1.51%

Acrivon Therapeutics Growth Metrics API

Pull Acrivon Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACRV&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY